Women

Women's Care Products


Mylan, a champion for Women's Health

Most Indian women experience health challenges throughout their lifetime, from adolescence to post-menopausal age. Mylan is committed to address the major health concerns among women in India, and aims to tackle these health issues in coordination with the Indian medical community, thereby ensuring timely access to affordable treatment and improving the quality of life for Indian women.

Health is an important factor that contributes to human well being and economic growth.

As in several countries, in India too, women do not have easy access to healthcare, which greatly compromises their social and economic status. From risks of miscarriages, infertility and other post-menopause related complications, women in India face numerous health issues, which ultimately affects the aggregate economy’s output. 

Approximately one in five pregnancies in Indian women end in miscarriage[1]. In addition, women who are in post-menopause may experience various short, medium and long-term complications, such as urogenital atrophy or osteoporosis.

Mylan aims to tackle these health issues through its women’s care segment, which focuses on treatments such as hormone replacement therapy, pre and post natal supplementation, post-menopause care and in-vitro fertilization treatments, such as follicle stimulating hormones, human menopausal gonadotropins and human chorionic gonadotropins.

Women in India face a number of health challenges, In addition, women who are in post-menopause may experience various short, medium and long term complications, such as urogenital atrophy or osteoporosis.

In addition to launching our innovative, high quality product portfolio, Mylan helps strengthen the capabilities of healthcare providers in this area through training programs and workshops, working together with the medical community, government and non-government organizations to address areas of concern in women's health and improve timely access to appropriate high quality treatment.

Mylan’s women’s health business spans more than 60 emerging-market countries, touching the lives of approximately 15 million women.





References:

1] Population Council. “Unintended Pregnancy and Abortion in India with Focus on Bihar, Madhya Pradesh and Odisha.2013. Available at:

https://www.popcouncil.org/uploads/pdfs/2014STEPUP_IndiaCountryProfile. pdf. Accessed on: 27 Jul 2017


Mylan a champion for Wellness 




Mylan with its wide range of high quality products is committed to make a difference in the life of every women. Mylan has stepped into one such area of general wellness with its products ranging from intimate hygiene to Androgenic product for sexual health.


The Wellness range, is geared to address lifestyle- related health concerns arising out of an urban, fast paced life.


Saugella Visna    MyEstra Frewil                 
        Saugella®                                            VISNA®                                     MyESTRA                                   FREWIL
                    


The product database is intended as a general reference source only and is not a substitute for qualified medical care from a licensed physician.


Mylan, a champion in Contraception



Marking our place as a leader in Contraception

5/10 Married women do not use modern contraceptive methods[1] 

1 in 4 Married women have unwanted pregnancies[2]; 50% Unintended pregnancies end in abortion[2]

For the last 15 years Mylan has been offering more than 15 birth control medications globally, in various dosage forms to help women plan their family at every stage of their life. 

Mylan is a global leader in the space of oral contraceptive pills (OCPs), and is the largest manufacturer OCPs, with a capacity of 48 crore cycles per year; it is the preferred Supplier to reputed pharma companies, globally.
Mylan is a trustworthy contraceptive solution provider because 1 out of 7 OCP users around the world, trust OCPs produced by Mylan.


Descon            Famycept            

Descon®      Famycept® YANCI®

  

                  Famylette® Tiup®                                        Dimple

 


References:

1.National Family Health Survey-4 India 2015-2016. Available at: http://rchiips.org/NFHS/pdf/NFHS4/India.pdf. Accessed on:17 Jul 2017.

2.Population Council. “Unintended Pregnancy and Abortion in India with Focus on Bihar, Madhya Pradesh and Odisha.2013. Available at:
https://www.popcouncil.org/uploads/pdfs/2014STEPUP_IndiaCountryProfile. pdf. Accessed on: 27 Jul 2017.

The product database is intended as a general reference source only and is not a substitute for qualified medical care from a licensed physician.


Mylan, delivering the dreams of women suffering from infertility 




2/10 Women (age,15–44 years) face infertility[1].

80% Women face fertility problems at their first conception[2].
1in10 Working women are at an increased risk of developing primary infertility[2].

Mylan offers high-quality, yet affordable, highly purified range of gonadotropins to deliver the dreams of women suffering from infertility. 

Mylan use high-end cold chain trucks to transport gonadotropins and uses sophisticated data loggers to check minor temperature excursions beyond 2–8°C, thus ensures product quality throughout the distribution chain.


           

                                MyHMG®   MyFSH®
      


     MyProg                                     

                MyProg™  MyHCG®


References:

[1]Baranwal A, Kunwar N, Tripathi S. Causes of Increasing Rate of Female Infertility in India. Int J Sci Res. 2013. Available at:http://www.ijsr.net/archive/v4i7/SUB156201.pdf. Accessed on: 24 Aug 2017.

[2] Sarkar S, Gupta P. Socio-Demographic Correlates of Women’s Infertility and Treatment Seeking Behavior in India. J Reprod Infertil. 2016; 17(2): 123–132.


The product database is intended as a general reference source only and is not a substitute for qualified medical care from a licensed physician.